Q85.81
PTEN hamartoma tumor syndrome
Clinical Classification Guidelines
Inclusion Terms
- PHTS
- PTEN related Cowden syndrome
Code Also
- , if applicable, genetic susceptibility to malignant neoplasm (Z15.0-)
Medical Intelligence & Overview
PTEN Hamartoma Tumor Syndrome (PHTS) is a genetic condition linked to mutations in the PTEN gene. It is characterized by the development of multiple noncancerous (benign) growths called hamartomas, and it can increase the risk of developing certain types of cancers. PHTS encompasses a group of disorders, including Cowden syndrome, which share common features related to PTEN gene mutations. Recognizing the signs and understanding the underlying causes can help in managing the condition effectively, although diagnosis and treatment should always be guided by healthcare professionals.
Causes & Symptoms
Clinical Causes: Mutations in the PTEN gene, which is responsible for controlling cell growth and division. Inherited genetic mutations passed down from parents (familial cases). De novo mutations that occur spontaneously without a family history.
Key Symptoms: Multiple benign growths (hamartomas) on the skin and mucous membranes. Lumpy or irregular skin lesions, including trichilemmomas and papillomas. Thyroid abnormalities, such as goiter or nodules. Macrocephaly, or an abnormally large head size. Increased risk for certain cancers, including breast, thyroid, endometrial, and renal cancers. Distinct pathognomonic features such as oral mucosal papillomatosis.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves clinical evaluation of physical features and personal or family history of related conditions. Genetic testing is crucial for confirming PTEN gene mutations. Imaging studies may be recommended to identify internal tumors or hamartomas, alongside regular screenings tailored to individual risk factors. Expert genetic counseling can help individuals understand the implications of the diagnosis, inheritance patterns, and management options.
Treatment Protocols: Regular screening for associated cancers, such as mammograms, thyroid ultrasounds, and colonoscopies. Surgical removal of problematic hamartomas or tumors. Managing skin lesions and mucosal growths as needed. Genetic counseling for affected families to understand inheritance and reproductive options. Coordination of care among specialists, including dermatologists, endocrinologists, oncologists, and geneticists.
Clinical Advice & FAQs
Billing Guidance
Is Q85.81 a billable ICD-10 code?
Yes, Q85.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q85.81?
Clinical documentation must specify the nature of PTEN hamartoma tumor syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
